LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 14.50 | 770.25 | 1325 | 1497 | 0.8850 | 0.7607 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 14.50 | 770.25 | 1236 | 1497 | 0.8255 | 0.6375 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 16.73 | 770.25 | 1209 | 1664 | 0.7263 | 0.5001 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 16.73 | 770.25 | 1239 | 1664 | 0.7444 | 0.5336 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 18.95 | 770.25 | 1399 | 1832 | 0.7634 | 0.6117 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 18.95 | 770.25 | 1271 | 1832 | 0.6936 | 0.4926 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 21.17 | 770.25 | 1348 | 2008 | 0.6712 | 0.4990 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 21.17 | 770.25 | 1198 | 2008 | 0.5965 | 0.3764 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 23.39 | 770.25 | 1425 | 2244 | 0.6349 | 0.4899 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 23.39 | 770.25 | 1263 | 2244 | 0.5627 | 0.3778 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 25.62 | 770.25 | 1333 | 2514 | 0.5301 | 0.3789 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 25.62 | 770.25 | 1102 | 2514 | 0.4382 | 0.2335 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 27.84 | 770.25 | 1400 | 2833 | 0.4940 | 0.3743 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 27.84 | 770.25 | 1040 | 2833 | 0.3670 | 0.1732 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 30.06 | 770.25 | 1386 | 3106 | 0.4462 | 0.3391 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 30.06 | 770.25 | 974 | 3106 | 0.3136 | 0.1237 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 32.28 | 770.25 | 1336 | 3392 | 0.3938 | 0.2936 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 32.28 | 770.25 | 1016 | 3392 | 0.2995 | 0.1382 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 34.50 | 770.25 | 1299 | 3712 | 0.3500 | 0.2591 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 34.50 | 770.25 | 1002 | 3712 | 0.2699 | 0.1229 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 36.73 | 770.25 | 1359 | 4086 | 0.3326 | 0.2660 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 36.73 | 770.25 | 972 | 4086 | 0.2379 | 0.1015 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 38.95 | 770.25 | 1262 | 4543 | 0.2777 | 0.2127 | MN20160304_L02 | K12 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 38.95 | 770.25 | 1077 | 4543 | 0.2370 | 0.1399 | MN20160304_L02 | M11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 41.17 | 770.25 | 1305 | 5010 | 0.2605 | 0.2155 | MN20160304_L02 | K12 |